OKYO Pharma (OKYO) Equity Ratio (2021 - 2025)

OKYO Pharma (OKYO) has 5 years of Equity Ratio data on file, last reported at 1.51 in Q1 2025.

• Equity Ratio for Q1 2025 came in at 1.51, up 60.44% year-over-year; the trailing twelve-month figure through Mar 2025 was 1.51 (up 60.44% YoY), and the FY2025 annual result was 1.51, up 60.44% from the prior year.
• Equity Ratio grew to 1.51 in Q1 2025 per OKYO's latest filing, from 51.33 in the prior quarter.
• Over five years, Equity Ratio peaked at 56.95 in Q3 2023 and troughed at 51.33 in Q3 2024.
• A 5-year average of 0.19 and a median of 0.39 in 2023 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio tumbled 866.85% in 2024, then surged 60.44% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.75 in 2021, then slipped by 8.64% to 0.69 in 2022, then jumped by 8209.98% to 56.95 in 2023, then slumped by 190.13% to 51.33 in 2024, then jumped by 97.06% to 1.51 in 2025.
• Business Quant data shows OKYO's Equity Ratio at 1.51 in Q1 2025, 51.33 in Q3 2024, and 3.81 in Q1 2024.